Performance outcomes of the <scp>PEDI</scp> ‐ <scp>CAT</scp> for assessing functional ability in the population with leukodystrophy
Stacy V Cusack(Children's Hospital of Philadelphia), Laura Adang(Children's Hospital of Philadelphia), Abbas F. Jawad(Children's Hospital of Philadelphia), Adeline Vanderver(Children's Hospital of Philadelphia), Sarah Woidill(Children's Hospital of Philadelphia), Allan M Glanzman(Children's Hospital of Philadelphia), Timothy Estilow(Children's Hospital of Philadelphia), Amy T Waldman(Children's Hospital of Philadelphia), Francesco Gavazzi(Children's Hospital of Philadelphia)
Cited by 0
Related Papers
Janus Kinase Inhibition in the Aicardi–Goutières Syndrome
|New England Journal of Medicine|2020|201
Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function
|Human Mutation|2020|115
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS
|Annals of the Rheumatic Diseases|2022|97
Developmental Outcomes of Aicardi Goutières Syndrome
|Journal of Child Neurology|2019|65
Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots
|Molecular Genetics and Metabolism|2017|52